Table 2. Assessment of relative risk for out of control values of blood pressure and heart rate producing by remifentanil compared to sufentanil in different data points compared to T0 (pre-induction).
| Remifetanil | Sufetanil | P value | Relative Risk | |||
|---|---|---|---|---|---|---|
| In control | Out of control | In control | Out of control | Out of control Remi/Suf | ||
| SBP | ||||||
| T1-T0 | 50%(10) | 50%(10) | 80%(16) | 20%(4) | 0.09 | 0.62 |
| T2-T0 | 65%(13) | 35%(7) | 45%(9) | 55%(11) | 0.34 | 1.44 |
| T3-T0 | 65%(13) | 35%(7) | 55%(11) | 45%(9) | 0.74 | 1.18 |
| T4-T0 | 70%(14) | 30%(6) | 55%(11) | 45%(9) | 0.51 | 1.27 |
| T5-T0 | 65%(13) | 35%(7) | 55%(11) | 45%(9) | 0.74 | 1.18 |
| DBP | ||||||
| T1-T0 | 15%(3) | 85%(17) | 25%(5) | 75%(15) | 0.69 | 0.60 |
| T2-T0 | 25%(5) | 75%(15) | 15%(3) | 85%(17) | 0.69 | 1.66 |
| T3-T0 | 40%(8) | 60% (12) | 20%(4) | 80%(16) | 0.30 | 2.00 |
| T4-T0 | 35%(7) | 65%(13) | 25%(5) | 75%(15) | 0.73 | 1.40 |
| T5-T0 | 30%(6) | 70(14) | 15%(3) | 85%(17) | 0.45 | 2.00 |
| MBP | ||||||
| T1-T0 | 25%(5) | 75%(15) | 45%(9) | 55%(11) | 0.32 | 0.55 |
| T2-T0 | 45%(9) | 55%(11) | 15%(3) | 85%(17) | 0.08 | 3.00 |
| T3-T0 | 35%/(7) | 65%(13) | 40%(18) | 60%(2) | 0.99 | 0.87 |
| T4-T0 | 50%(10) | 50%(10) | 30%(6) | 70%(14) | 0.33 | 1.66 |
| T5-T0 | 35%(7) | 65%(13) | 25%(5) | 75%(15) | 0.73 | 1.40 |
| HR | ||||||
| T1-T0 | 85%(17) | 15%(3) | 55%(11) | 45% (9) | 0.08 | 1.54 |
| T2-T0 | 85%(17) | 15%(3) | 40%(8) | 60%(12) | 0.00* | 2.12* |
| T3-T0 | 90%(18) | 10%(2) | 55%(11) | 45%(9) | 0.03* | 1.63* |
| T4-T0 | 95%(19) | 5%(1) | 65%(13) | 35%(7) | 0.04* | 1.46* |
| T5-T0 | 80%(16) | 20%(4) | 65%(13) | 35%(7) | 0.48 | 1.23 |
*Relative risk more than 1 is significant if p value <0.05.